Literature DB >> 19293719

Clinical meaning of pepsinogen test and Helicobacter pylori serology in the health check-up population in Korea.

Hyun Young Kim1, Nayoung Kim, Jung Mook Kang, Young Soo Park, Dong Ho Lee, Yu Rim Kim, Joo Sung Kim, Hyun Chae Jung, In Sung Song.   

Abstract

OBJECTIVE: This study was performed to assess the affects of age, sex, and Helicobacter pylori status on pepsinogen testing for atrophic gastritis and to establish the clinical implications of pepsinogen test results and H. pylori serology in a Korean population presenting for a health check-up.
METHODS: Serum pepsinogen (PG) I and PG II, and H. pylori IgG were measured in 1485 adults. The PG values were analyzed based on age, sex, and H. pylori status, and the cutoff value for atrophic gastritis was determined.
RESULTS: Serum PG I (sPGI) and sPGII were higher in H. pylori positive than in H. pylori negative individuals (sPGI, 56.3 vs. 42.2 microg/l, P<0.001; sPGII, 17.5 vs. 8.0 microg/l, P<0.001). The PG I/II ratio was lower in H. pylori positive than in H. pylori negative individuals (3.7 vs. 6.0, P<0.001). The sPGII and PG I/II ratio had a positive (r=0.132, P<0.001) and negative correlation with age (r=-0.229, P<0.001), respectively. Men had a higher sPGI (54.7 microg/l) than did women (48.4 microg/l) (P<0.001) but the PG I/II ratio was not statistically different and neither the atrophic gastritis. The PG I/II cutoff value for atrophic gastritis was 6.0 for H. pylori negative and 3.0 for H. pylori positive individuals. sPGI and sPGII were, however, not specific for atrophic gastritis.
CONCLUSION: The H. pylori IgG status, age, and sex were associated with the serum PG levels. To increase the efficacy of the PG I/II ratio for the detection of atrophic gastritis, the cutoff value of the PG I/II ratio should be stratified according to the H. pylori IgG status in the Korean population presenting for a health check-up.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19293719     DOI: 10.1097/MEG.0b013e3283086757

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  19 in total

1.  Helicobacter pylori infection increases the risk of colorectal adenomas: cross-sectional study and meta-analysis.

Authors:  Sung Noh Hong; Seung Min Lee; Jeong Han Kim; Tae Yoon Lee; Jeong Hwan Kim; Won Hyeok Choe; Sun-Young Lee; Young Koog Cheon; In Kyung Sung; Hyung Seok Park; Chan Sup Shim
Journal:  Dig Dis Sci       Date:  2012-06-06       Impact factor: 3.199

2.  The new modified ABCD method for gastric neoplasm screening.

Authors:  Chan Hyuk Park; Eun Hye Kim; Da Hyun Jung; Hyunsoo Chung; Jun Chul Park; Sung Kwan Shin; Sang Kil Lee; Yong Chan Lee
Journal:  Gastric Cancer       Date:  2015-02-08       Impact factor: 7.370

3.  Comparison of serum trefoil factor 3 with the pepsinogen test for the screening of diffuse-type gastric cancer.

Authors:  Ju Yup Lee; Kyung Sik Park; Hyun-Gyo Lee; Won-Ki Baek; Kwang Bum Cho; Yoo Jin Lee; Yoon Suk Lee; Seung-Wan Ryu
Journal:  Clin Exp Med       Date:  2016-05-06       Impact factor: 3.984

4.  The role of serum pepsinogen in the detection of gastric cancer.

Authors:  Nayoung Kim; Hyun Chae Jung
Journal:  Gut Liver       Date:  2010-09-24       Impact factor: 4.519

5.  Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED).

Authors:  M Dinis-Ribeiro; M Areia; A C de Vries; R Marcos-Pinto; M Monteiro-Soares; A O'Connor; C Pereira; P Pimentel-Nunes; R Correia; A Ensari; J M Dumonceau; J C Machado; G Macedo; P Malfertheiner; T Matysiak-Budnik; F Megraud; K Miki; C O'Morain; R M Peek; T Ponchon; A Ristimaki; B Rembacken; F Carneiro; E J Kuipers
Journal:  Virchows Arch       Date:  2011-12-22       Impact factor: 4.064

6.  Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED).

Authors:  M Dinis-Ribeiro; M Areia; A C de Vries; R Marcos-Pinto; M Monteiro-Soares; A O'Connor; C Pereira; P Pimentel-Nunes; R Correia; A Ensari; J M Dumonceau; J C Machado; G Macedo; P Malfertheiner; T Matysiak-Budnik; F Megraud; K Miki; C O'Morain; R M Peek; T Ponchon; A Ristimaki; B Rembacken; F Carneiro; E J Kuipers
Journal:  Endoscopy       Date:  2011-12-23       Impact factor: 10.093

7.  Detection of gastric atrophy by circulating pepsinogens: A comparison of three assays.

Authors:  Marcis Leja; M Constanza Camargo; Inese Polaka; Sergejs Isajevs; Inta Liepniece-Karele; Dainius Janciauskas; Dace Rudzite; Ilze Kikuste; Aigars Vanags; Ilona Kojalo; Valdis Folkmanis; Arnis Kirsners; Ivars Tolmanis; Charles S Rabkin
Journal:  Helicobacter       Date:  2017-05-29       Impact factor: 5.753

8.  Helicobacter pylori infection, atrophic gastritis, and risk of pancreatic cancer: A population-based cohort study in a large Japanese population: the JPHC Study.

Authors:  Mayo Hirabayashi; Manami Inoue; Norie Sawada; Eiko Saito; Sarah K Abe; Akihisa Hidaka; Motoki Iwasaki; Taiki Yamaji; Taichi Shimazu; Shoichiro Tsugane
Journal:  Sci Rep       Date:  2019-04-15       Impact factor: 4.379

9.  Serum pepsinogen II is a better diagnostic marker in gastric cancer.

Authors:  Xue-Yuan Cao; Zhi-Fang Jia; Mei-Shan Jin; Dong-Hui Cao; Fei Kong; Jian Suo; Jing Jiang
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

10.  Increase in plasma acyl ghrelin levels is associated with abatement of dyspepsia following Helicobacter pylori eradication.

Authors:  Yoon Jin Choi; Nayoung Kim; Hyuk Yoon; Cheol Min Shin; Young Soo Park; Ji Hyun Park; Ryoung Hee Nam; Dong Ho Lee; Hyun Chae Jung
Journal:  J Gastroenterol       Date:  2015-09-28       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.